Dyphylline / guaifenesin Pregnancy and Breastfeeding Warnings

Brand names: D-G, Difil G, Difil-G Forte, Dilex-G, Dilex-G 200, Dilex-G 400, Dilor-G, Dy-G, Dyfilin GG, Dyflex-G, Dyline GG, Dyphyl GG, Dyphyllin-GG, Dyphylline GG, Dyphylline GG ES, Jay-Phyl, LGG, Lufyllin-GG, Panfil G

Medically reviewed by Drugs.com. Last updated on Aug 3, 2023.

Dyphylline / guaifenesin Pregnancy Warnings

Animal studies have not been conducted. There are no controlled data in human pregnancy. It is unknown if this drug can cause fetal harm or affect reproduction capacity.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

This drug should be used during pregnancy only if clearly needed.

US FDA pregnancy category: C

See references

Dyphylline / guaifenesin Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: Yes

Comments:
-Dyphylline is present in human milk at about twice the maternal plasma concentration.

See references

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer